Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
49.31
-1.28 (-2.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
February 02, 2022
Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials...
Via
FinancialNewsMedia
Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential
January 24, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 24, 2022 – USA News Group – Within the grand battle against cancer, the use of immunotherapy continues to grow at...
Via
FinancialNewsMedia
Unusual Options Activity Insight: Exact Sciences
August 13, 2021
Exact Sciences (NASDAQ:EXAS) shares experienced unusual o...
Via
Benzinga
Unusual Options Activity Insight: Exact Sciences
August 03, 2021
On Tuesday, shares of Exact Sciences (NASDAQ:EXAS) saw un...
Via
Benzinga
Expert Ratings for Exact Sciences
July 29, 2021
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the fol...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
January 14, 2022
One of the best-known and well-covered ETF companies over the past five years has been ARK Invest, led by Cathie Wood. With t...
Via
Benzinga
Why Exact Sciences Share Are Falling Today?
January 10, 2022
Exact Sciences Corp (NASDAQ: EXAS) has put down $190 million to buy testing laboratory PreventionGenetics, aiming to expand its diagnostics franchise into...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
2 Reasons to Buy Exact Sciences Stock, and 1 Reason to Sell
December 07, 2021
Its positioning in cancer diagnostics is good, but it faces an important headwind.
Via
The Motley Fool
Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods
December 01, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the...
Via
FinancialNewsMedia
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
December 01, 2021
The end of a co-promotion deal with Pfizer could work out well for Exact Sciences.
Via
The Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...
Via
Benzinga
Exposures
Product Safety
Pfizer Will Not Co-Promote Exact Sciences Colorectal Cancer Screening Test
November 30, 2021
Exact Sciences Corporation (NASDAQ: EXAS) says that Pfizer Inc (NYSE: PFE) will no longer join the Company from November 30 to promote its Cologuard colorectal...
Via
Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
The internet's favorite stock picker has been very busy.
Via
The Motley Fool
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
November 11, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force...
Via
FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
November 03, 2021
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
November 03, 2021
Needham boosted Paycom Software, Inc. (NYSE:PAYC) ...
Via
Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
November 03, 2021
Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...
Via
Benzinga
Exact Sciences Shares Drop After Guiding Lower Screening Revenue For FY21
November 03, 2021
Exact Sciences Corp's (NASDAQ: EXAS) Q3 revenues rose 12% Y/Y to $456.4 million, beating the consensus of $430.03 million. The increase is attributable to increased...
Via
Benzinga
Exact Sciences (EXAS) Q3 2021 Earnings Call Transcript
November 03, 2021
EXAS earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
Why Exact Sciences' Stock Is Trading Higher Today
September 15, 2021
Exact Sciences (NASDAQ:EXAS) shares are trading higher after the company announced an expansion of its primary care sales team with the addition of former Pfizer sales...
Via
Benzinga
3 Crash-Ready Stocks to Buy in September
September 14, 2021
History says this month can be scary. These stocks can get you through it.
Via
The Motley Fool
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused...
Via
Benzinga
3 Top Healthcare Stocks to Buy for August
August 19, 2021
With excellent prospects, these three companies are built to last and today's prices are attractive.
Via
The Motley Fool
44 Stocks Moving In Thursday's Mid-Day Session
July 29, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....
Via
Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving in Thursday's Pre-Market Session
July 29, 2021
Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.